SONALASENSE
SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors. It utilizes MRI-guided focused ultrasound (the device) in combination with aminolevulinic acid (a drug) to selectively target and kill tumor cells. Their use of an MRI-guided focused ultrasound device with ALA is a true drug-device combination, where both the drug and the device are required for a therapeutic effect. SDT has a well-elucidated mechanism of action (creation of reactive oxygen species). The company was founded in 2019 and is based in Berkeley, California.
SONALASENSE
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2019-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.sonalasense.com
Total Employee:
1+
Status:
Active
Contact:
510-831-2220
Total Funding:
21.09 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Radetec Diagnostics
Revolutionary Point-Of-Care detection of COVID-19 and STIs
RainTree Oncology Services
RainTree Oncology Services provides oral drug acquisition and management services for patients with cancer.
Nanoxort
Nanoxort develops diffusive magnetic fractionation technology to enable explicit control of the properties of magnetic nanomaterials.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
NOVO Health
NOVO Health represents independent physicians that offer specialty healthcare solutions to businesses and organizations.
Minerva Biotechnologies
Minerva Biotechnologies develops cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis.
Magnus Medical
Magnus Medical develops a closed-loop neuromodulation technology to effectively treat intractable neurological and psychiatric disorders.
MRI Online
MRI Online is an e-learning platform that provides the largest collection of online MRI teaching cases and courses for radiologists.
MicroBplex
MicroBPlex is developing a diagnostic platform to identify microbial infections.
Quadrant Biosciences
Quadrant Biosciences develop, test, and distribute products with expertise in engineering, production, marketing, and sales.
LEAA
We Do MEDICAL HOUSE CALLS - BA.5, MONKEYPOX TEST, EVUSHELD FOR COVID, X-RAY AT HOME , BLOOD WORK, OMICRON EX, MONOCLONAL, BEBTELOVIMAB.
Langaware
Langaware predicts neurodegenerative diseases by detecting and monitoring digital biomarkers based on language and speech.
AMBICION
AMBICION develops new drugs focused on establishing a global standard treatment for cancer patients.
Avivomed
Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.
Animated Dynamics
Animated Dynamics (AniDyn) Inc. is located in the Kurz Purdue Technology Center in West Lafayette IN.
Alpheus Medical
Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.
Astarte Medical
Astarte Medical is clinical intelligence company providing digital solutions to support protocol-driven care across pediatric populations.
ABT Molecular Imaging
ABT Molecular Imaging develops a production platform to generate unit doses of molecular imaging drugs for PET scanning at the point of use.
Kenota Health
Kenota Health develops next-generation diagnostic tools intended to be used for allergy testing in humans.
Early Detection
Early Detection develops non-invasive and accurate screening tests for an abnormal sugar molecule expressed only in cancer.
EvoEndo
EvoEndo develops systems that enable unsedated endoscopic procedures through a combination of sterile single-use.
EZaccessMD
EZaccessMD is offering 24/7 telemedicine physician consultation, with on-demand mobile diagnostic teams to their home or work.
Biop-Medical
Focused on the development of next-generation diagnostics for identifying cancer in epithelial cells.
Biotesserae Camunity
Biotesserae Camunity develops a nanobody-based platform designed for canine cancer treatments.
Butterfly Labs
Butterfly Labs enables telehealth companies to quickly and easily get started with at-home testing.
Sonoclear AS
BrainImage is the provider of SonoClear® - an acoustic coupling fluid for enhanced ultrasound imaging.
Elemy
Elemy is the nationwide provider of childhood mental and behavioral healthcare.
TrackX Technology
TrackX Technology develops a tracking technology that provides real-time virtual live fluoroscopy.
Third Eye Diagnostics
Third Eye Diagnostics develops a non-invasive intracranial pressure monitor that gathers information from the patient's eye.
Teiko.bio
Teiko.bio is an immune profiling platform that enables clinicians to make informed decisions around patient response.
TRACT Therapeutics
TRACT Therapeutics develops a novel approach for restoring immune balance in patients receiving a solid organ transplant.
Unravel Biosciences
The first rapid prototyping therapeutics company
UniXell
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.
KayoThera
KayoThera develops therapeutics used to cure late-stage and metastatic cancers.
Kipu Health
SaaS platform for behavioral health and addiction treatment centers providing EHR, patient engagement and RCM solutions.
Sonire Therapeutics
Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.
Sonocine
SonoCine develops and markets an imaging solution for breast cancer screening.
Sonex Health
Sonex Health reduces invasiveness, improves safety, and lowers the cost of care through transformative ultrasound.
Sonnest, Inc.
Sonnest offers electrically sensitive imaging agent for assessing and monitoring the perfusion, structure, and function of the heart.
StoryMD
StoryMD develops a unified digital health platform that translates health and wellness data into a personal story.
SoniVie
SoniVie Ltd develops an advanced denervation solution
DemeRx
DemeRx, Inc. develops treatment for drug addiction among patients coping with chronic pain.
Discovery Sound Technology
Discovery Sound Technology provides ultrasound diagnostic tools for predictive maintenance programs.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Diag-Nose Medical
Diag-Nose Medical is a novel diagnostic tool that develops non-Invasive diagnostics for better rhinology treatments.
Delphi Diagnostics
Provider of a diagnostic and predictive testing process for the treatment of breast cancer.
BOKA Sciences
BOKA Sciences develops human hydration assessment tests using biomarkers found in saliva.
Haystack Dx
Haystack Dx developed a complete solution to address the clinical unmet need to improve the diagnostic procedure for neuromuscular disorder.
IntelligentMDx
IntelligentMDx develops innovative molecular diagnostic tests to maximize both patient impact and stakeholder value.
Ingenious Med
Ingenious Med develops and delivers inpatient practice management information systems in the United States.
IQuity
IQuity and Decode Health have joined operations effective May 2022.
Ena Respiratory
Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
GI-View
GI View Ltd. develops devices for diagnosing and treating gastrointestinal disorders. Its product includes Aer-O-Scope, a disposable,
Oculogica
Oculogica specializes in the fields of neuro-diagnostics, brain injury, TBI, concussion, and eye tracking.
Otologic Technologies
Otologic Technologies develops a diagnostic artificial intelligence system for ear diseases.
XOR Labs Toronto
Advances in medical science have introduced the era of personalized medicine for organs.
XOStem
XOStem is the stem cell expert that creates the next generation treatment for Type 1 Diabetes and produces Engineered Exosomes.
CytoVeris
CytoVeris develops optical-based probes enabling surgical oncologists to identify and remove tumor tissue during cancer resection surgery.
CASPR Biotech
CASPR Biotech develops a CRISPR-based platform for molecular detection.
Cambridge Raman Imaging
Cambridge Raman Imaging is developing a microscope which uses graphene to modulate ultra-short pulses of light to diagnose cancer tumours.
Corus Orthodontists
Corus Orthodontists is an orthodontic partnership network that provides exceptional patient care and preserves patient-doctor relationships.
ClearChoice Holdings
ClearChoice is a network of dental treatment centers that provide innovative and quality dental implant care across the United States.
Parsley Health
Parsley Health is redesigning primary care by integrating the latest in medical testing, technology and nutrition research.
ProteoWise
ProteoWise offers a technology that provides a unique combination of high information content, high throughput, and low cost.
Portela Soni Medical
Portela Soni Medical is a developer of a catheter device designed to solve problems for patients in novel and innovative ways.
Piedmont Stone Center
Piedmont Stone Center provides non-surgical treatment using Extracorporal Shock Wave Lithotripsy of kidney stones to their patients.
Prevencio
Prevencio is a developer of multi-proteomic biomarkers designed to revolutionize blood tests for cardiovascular disease.
Proteoform Scientific
Proteoform empowers researchers with new technology to simplify protein sample preparation in both top-down and bottom-up proteomics.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Current Employees Featured
Founder
Official Site Inspections
http://www.sonalasense.com Semrush global rank: 7.27 M Semrush visits lastest month: 548
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "SonALAsense"
About Us | SonALAsense
SonALAsense is led by an experienced leadership team and Scientific Advisory Board of Key Opinion Leaders and is the first company to advance SDT into clinical trials. Our leadership has developed multiple drugs and drug-device …See details»
Team (All) - SonALAsense
SonALAsense is led by an experienced leadership team and Scientific Advisory Board and is the first company to advance sonodynamic therapy into Phase 2 clinical trials. Our leadership has …See details»
SonALAsense - Crunchbase Company Profile & Funding
SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors. It utilizes MRI-guided focused ultrasound (the device) in …See details»
SonALAsense - LinkedIn
SonALAsense is a clinical-stage company developing ALA sonodynamic therapy (SDT) as a first-in-class, non-invasive drug-device combination for the treatment of recurrent glioblastoma multiforme ...See details»
SonALAsense Company Profile 2024: Valuation, Funding
SonALAsense General Information Description. Developer of an SDT device designed to turn glioblastoma multiforme patients into cancer survivors. The company's non-invasive drug …See details»
SonALAsense Achieves Significant Clinical, Growth and …
Jun 28, 2022 About SonALAsense SonALAsense is a clinical-stage company developing sonodynamic therapy (SDT) as a first-in-class, noninvasive drug-device combination for the treatment of recurrent glioblastoma ...See details»
SonALAsense - Contacts, Employees, Board Members, Advisors
SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors.See details»
FDA Grants Fast Track Designation to SonALAsense’s SONALA-001 …
OAKLAND, Calif., November 14, 2023--SonALAsense, a pioneer in the development of non-invasive Sonodynamic Therapy (SDT) using SONALA-001, today announced that the United …See details»
FDA Grants Fast Track Designation to SonALAsense’s SONALA-001 …
Nov 14, 2023 About SonALAsense. SonALAsense is a clinical-stage company, developing a proprietary form of sonodynamic therapy (SDT) as a first-in-class, noninvasive drug-device …See details»
Dr. Stuart Marcus Creates SonALAsense To Treat …
Feb 3, 2022 Dr. Stuart Marcus is the founder and Chief Medical Officer of SonALAsense, founded in 2019 to provide a non-invasive, drug-device combination treatment of recurrent glioblastoma multiforme (rGBM ...See details»
SonALAsense Achieves Significant Clinical, Growth and Funding ...
Oakland, CA, June 28, 2022—SonALAsense, a pioneer in the development of SONALA-001 and sonodynamic therapy (SDT), a new drug-device combination developed to manage deadly …See details»
SonALAsense - Argus
SonALAsense’s mission is to turn glioblastoma multiforme (GBM) patients into cancer survivors by turning GBM from deadly cancer into a chronic disease SonALAsense approached Argus to …See details»
SonALAsense Pioneers Sonodynamic Therapy, a First-in-Class …
Dec 14, 2020 SonALAsense is a clinical-stage company developing ALA sonodynamic therapy (SDT) as a first-in-class, non-invasive drug-device combination for the treatment of recurrent …See details»
SonALAsense Forges Ahead with First Patient Dosing for …
Sep 13, 2022 SonALAsense is the first clinical-stage company developing sonodynamic therapy (SDT) as a first-in-class, noninvasive drug-device combination for the treatment of recurrent …See details»
Ivy Brain Tumor Center and SonALAsense Announce Positive
Sep 20, 2021 About SonALAsense SonALAsense is a clinical-stage company developing sonodynamic therapy (SDT) as a first-in-class, noninvasive drug-device combination for the …See details»
For Patients - SonALAsense
The SonALAsense SDT Procedure After the patient intravenously receives a dose of the drug, SONALA-001, the MRI is used to focus ultrasound waves from the approximately 1,000 …See details»
FDA Grants Fast Track Designation to SonALAsense’s SONALA-001
Nov 20, 2023 SonALAsense, a pioneer in the development of non-invasive Sonodynamic Therapy (SDT) using SONALA-001, today announced that the United States Food and Drug …See details»
SonALAsense Presents Preliminary Data From Clinical Study in …
OAKLAND, Calif., December 13, 2023--SonALAsense, a pioneer in the development of non-invasive Sonodynamic Therapy (SDT) using SONALA-001 (aminolevulinic acid HCl) in …See details»
News (All) - SonALAsense
Jun 21, 2022 SonALAsense presents preliminary data from clinical study in patients with deadly pediatric brain tumor . December 13, 2023. ... Learn more about Cancer Commons, an …See details»